Jeff Aronin has a passion for helping his patients. His belief that he can help people live better lives is the reason Jeff began to research and develop medicines. These medicines have been created specifically for people with medical needs that are unmet.
Jeff Aronin worked in the healthcare field for years before he moved to become the CEO of Ovation Pharmaceuticals. Jeff wanted to do more for his patients, and he felt that the best way to complete this passion was to create an entirely new business with a focus on patients with special needs.
Aronin has also worked on Paragon Biosciences, which is a company that also focuses on unmet needs in the medical field. Paragon has been responsible for creating companies such as Castle Creek Pharmaceuticals and Harmony Biosciences. The mission of Paragon Biosciences is to find medical breakthroughs for patients who are in need. Over the past decade, they have had over 10 FDA drug approvals. Paragon has put its expertise to use to accelerate scientific breakthroughs with their patients’ needs as their focal point.
The success of Jeff Aronin has allowed him to support the medical community is a variety of ways. He is a member of the board of directors for World Business Chicago and he was appointed to the board of directors for Discover Financial Services. He is also heavily involved in other causes that are local. He tends to focus his time and effort on healthcare businesses that are in different development stages.
Along with Aronin’s passion to help the less fortunate in the medical field, he has many years of experience leading and working with global companies. His business skills include strategic business development and brand marketing. He also has experience with strategic corporate transactions.
These skills have allowed Jeff Aronin to build several global companies that are very successful.
In a recent interview, Jorge Moll a renowned Neurologist explained where the idea to start D’Or Institute for Research and Education came from. He stated that it has always been his dream and passion to develop a state of the art neurology research and education centre in Brazil, his home country. Jorge Moll is a strong believer of exchanging of information between various people. Therefore, his day usually entails having a lot of meetings. He stated that he talks a lot with students, scientists and researchers from several organizations.
Although there are usually several ideas on his table, Jorge Moll usually chooses the one that can be converted into a plan of action in order to bring the idea to life. From an entrepreneur’s perspective, Jorge Moll advice people especially businessmen to be open, transparent and skillful so as to be productive. Furthermore, he advised other businessmen to always refrain from doing things over and over again. He also stated that it is key to always question your model of doing things.
To a younger version of himself, Jorge Moll stated that he would strongly advise himself to never hold on to an idea for too long. Either executes the idea or move on to another one very fast. Driven by the quote “Simplicity is the Ultimate Sophistication” by Davinci, Jorge Moll recommends the book “The Exegesis” by Philip Dick to anyone who loves reading.
Founder and President of D’or Institute for Research and Education, Jorge Moll is a household name in the medical field of neurology. Based in Rio de Janeiro, D’Or Institute for Research and Education is a private organization that promotes scientific research and technological progress in healthcare and excellence in education.
Jorge Moll attended the Federal University of Rio de Janeiro, Brazil where he earned an MD in Neuroscience upon graduation. It was also from the same University that Jorge Moll completed his residency from. He went ahead to join the Sao Paulo University and it was from there that he received a Ph.D. in Experimental Patho-physiology. Jorge Moll’s desire to help people with disorders that affect their day to day lives negatively is what made him start D’or Institute for Research and Education.